Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04927715
Other study ID # Soh-Med-21-02-26
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 20, 2021
Est. completion date February 28, 2022

Study information

Verified date January 2022
Source Sohag University
Contact Ali mo Altaher, lecturer
Phone 01003376529
Email dr.ali.altaher30@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

this is an observertional study aimed at Study the association between the level of irisin expression and (Fibronectin Type III Domain Containing 5 (FDNC5) gene polymorphism in female patients with peripartum cardiomyopathy.


Recruitment information / eligibility

Status Recruiting
Enrollment 45
Est. completion date February 28, 2022
Est. primary completion date January 30, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - This study will include females aged between 18 and 45 years old who have been diagnosed and treated clinically for peripartum cardiomyopathy Exclusion Criteria: - Age less than 18 or more than 45 year old - females with dilated cardiomyopathy due to other etiology or outside the time frame of occurrence of peripartum cardiomyopathy

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Egypt Sohag uniersity hosoital Sohag

Sponsors (1)

Lead Sponsor Collaborator
Sohag University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Irisin level detect the serum level of irisin hormone by ELIZA in nanogram/decilitre(ng/dl) 4 months
Primary FNDC5 Genotyping whether homogenetic or heterogenetic 4 months
See also
  Status Clinical Trial Phase
Completed NCT04144660 - "Treatment Use of ECMO In Pregnancy or Peripartum Patient."
Withdrawn NCT04143997 - Diastolic Dysfunction PPCM in Patients With Documented Left Ventricular Systolic Function Recovery
Completed NCT00998556 - Effect of Bromocriptine on Left Ventricular Function in Women With Peripartum Cardiomyopathy Phase 2
Completed NCT03081949 - Peripartum Cardiomyopathy in Nigeria Registry Phase 4
Recruiting NCT03364140 - A Registry of Peripartum Cardiomyopathy in Turkey N/A
Completed NCT04049136 - NT-proBNP Levels and Obesity in Pregnancy
Recruiting NCT04234659 - PPCM Observational Study (Peripartum Cardiomyopathy)
Withdrawn NCT02590601 - Bromocriptine in the Treatment of Peripartum Cardiomyopathy Phase 3
Completed NCT03907267 - Taurine in Peripartum Cardiomyopathy Phase 2/Phase 3
Recruiting NCT05878041 - Creation of a Multicenter National Registry for Peripartum Cardiomyopathy.